Lexpos News

/Lexpos News

Pharmacy First: Have you claimed for your March-May consultations?

As announced last month, Pharmacy First consultations carried out in March, April and May 2025 must be claimed by 11.59pm on 30th June 2025 to receive payment. Pharmacy owners are encouraged to check that all claims for this time period have been submitted to the NHS Business Services Authority on the MYS portal for payment. [...]

The post Pharmacy First: Have you claimed for your March-May consultations? appeared first on Community Pharmacy England.

By |June 23rd, 2025|Lexpos News|Comments Off on Pharmacy First: Have you claimed for your March-May consultations?

Eastern and East and North Midlands Pharmacy Owners: Book on your local Future of Pharmacy workshop

With the conclusion of the NHS 10-Year Health Plan imminent, this is a critical time for community pharmacy and it is important that we focus on the future, including looking at negotiating priorities to further leverage community pharmacy’s position. Pharmacy owners across the East of England and East and North Midlands are invited to ‘Future [...]

The post Eastern and East and North Midlands Pharmacy Owners: Book on your local Future of Pharmacy workshop appeared first on Community Pharmacy England.

By |June 20th, 2025|Lexpos News|Comments Off on Eastern and East and North Midlands Pharmacy Owners: Book on your local Future of Pharmacy workshop

Medicine Supply Notification: Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches MSN/2025/038 Tier 2 – medium impact Date of issue: 19/06/2025 Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour and 70micrograms/hour transdermal patches are out of stock until early August [...]

The post Medicine Supply Notification: Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches appeared first on Community Pharmacy England.

By |June 19th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches

June 2025 Price Concessions 1st Update

The Department of Health and Social Care (DHSC) has today (19/06/2025) confirmed the following initial list of price concessions for June 2025: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £6.21 Amiodarone 200mg tablets 28 £2.39 Betamethasone 500microgram soluble tablets sugar free 100 £36.00 Clarithromycin 125mg/5ml oral suspension 70 £6.08 Clarithromycin 250mg/5ml oral suspension 70 [...]

The post June 2025 Price Concessions 1st Update appeared first on Community Pharmacy England.

By |June 19th, 2025|Lexpos News|Comments Off on June 2025 Price Concessions 1st Update

Approaching deadline: Nearly 50% of pharmacies still to submit Data Security Toolkit

More than half of pharmacy owners are yet to complete their Data Security and Protection Toolkit 2025 ahead of the imminent deadline in less than two weeks. Community Pharmacy England has published guidance to help community pharmacy owners complete the Data Security and Protection Toolkit 2025. The Toolkit is used to make a pharmacy’s information [...]

The post Approaching deadline: Nearly 50% of pharmacies still to submit Data Security Toolkit appeared first on Community Pharmacy England.

By |June 18th, 2025|Lexpos News|Comments Off on Approaching deadline: Nearly 50% of pharmacies still to submit Data Security Toolkit